Xianguo Cai et al. studied the role of miRNA‐433 in renal cancer in 2020, and demonstrated for the first time that miRNA‐433 inhibitors can significantly reverse cell growth and migration caused by PCGEM1 downregulation,55 This study explored the molecular mechanisms underlying renal carcinogenesis and revealed molecular‐mediated therapies for renal cancer. This evidence concerns the gene PCGEM1 and renal carcinoma.